Medication info
Rilont Plus Tablet

Rilont Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Light orange oval film-coated tablets
Packaging
4 tablets/Blister
Approval status
Active

MFDS item code 201604705 · Approved 2016.07.29 · Insurance code 640903270

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this medicine, so take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it while sitting or standing upright with plenty of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to800 IU. Taking this medicine once weekly provides one week’s supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
The safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this medicine, so take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it while sitting or standing upright with plenty of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to800 IU. Taking this medicine once weekly provides one week’s supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

The safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medication may irritate the stomach and esophagus, leading to problems such as esophagitis or esophageal ulcers. It should be taken with a sufficient amount of water and must not be taken lying down for 30 minutes afterward. If symptoms such as pain in the esophagus or difficulty swallowing occur, discontinue use immediately and consult a physician. Patients with esophageal strictures or severe kidney impairment, as well as those allergic to the components of this medication, should not take it. The effectiveness of this medication may decrease if there is a lack of calcium and vitamin D, so it is advisable to take supplements if necessary. Caution should be exercised in the case of dental surgery or oral infections as there is a risk of osteonecrosis of the jaw, and oral health status should be discussed with a doctor. There may be interactions with other medications or foods while taking this drug, so inform the physician of any medications currently being taken. Women who are pregnant or breastfeeding should consult a doctor before using this medication. Safety in children has not been established, so use is not recommended. Overdose may present symptoms of hypocalcemia, and in case of symptoms, immediate consultation with healthcare personnel is necessary. This medication should be stored out of reach of children, and it is advisable not to transfer it to another container.

Side effects

Hemorrhage, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, dysphagia, odynophagia, retrosternal pain, heartburn, gastric ulcer, duodenal ulcer, infection, low back pain, pain, abdominal pain, neck pain, malaise, chest pain, neoplasm, hernia, hypertension, cardiovascular diseases, angina, nausea, diarrhea, bloating, gastritis, gastrointestinal diseases, rectal diseases, dental diseases, petechiae, anemia, arthralgia, joint abnormalities, myalgia, bone pain, bone abnormalities, leg cramps, bursitis, tendon abnormalities, depression, dizziness, insomnia, anxiety, neuralgia, vertigo, hypertonia, sensory abnormalities, pharyngitis, rhinitis, dyspnea, pneumonia, rash, pruritus, skin cancer, cataract, conjunctivitis, otitis media, urinary tract infection, cystitis, duodenitis, glossitis, abnormal results of various function tests, decreased serum calcium, decreased serum phosphorus, fever, influenza-like symptoms, injuries from accidents, epidemic cold syndrome, headache, overdose, allergic reaction, tumor, constipation, dyspepsia, nausea, gastroenteritis, colitis, vomiting, thirst, peripheral edema, traumatic fracture, myotonia, arthritis, bronchitis, sinusitis, increased cough, vasodilation, syncope, facial swelling, hair loss, dysosmia, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, blisters, dermatological hypersensitivity, jaw necrosis, liver dysfunction, jaundice, external ear bone necrosis, loss of appetite, chest discomfort, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever, fatty liver, increased serum alkaline phosphatase, edema, dry mouth, epigastric pain, abdominal distension, hiatal hernia, influenza, nasopharyngitis, bronchitis, upper respiratory tract infection, low back pain, osteoarthritis, limb pain, muscle rigidity, cervical pain, weakness, falls, dizziness, hypercholesterolemia, cough, depression, hypercalcemia, hypercalciuria, loss of appetite, polyuria, weakness, drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent exposure to air or moisture, and it is safe to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the drug's efficacy for an extended period.

Appearance and packaging

Appearance

Light orange oval film-coated tablets

Package unit

4 tablets/Blister

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.